Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination

American Journal of Therapeutics

Volumn 7, Issue 3, 2000, Pages 177-184

  Prisant, L Michael ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Ambulatory blood pressure; Combination drug therapy; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; DILTIAZEM; INDAPAMIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034189542     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200007030-00005     Document Type: Article

References (39)

1. Frishman WH, Charlap S, Ocken S, Spivack C: Calcium-channel blockers and systemic hypertension. J Clin Hypertens 1985;1:107-122.
2. Halperin AK, Cubeddu LX: The role of calcium channel blockers in the treatment of hypertension. Am Heart J 1986;111:363-382.
3. Montamat SC, Abernethy DR: Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertension. Clin Pharmacol Ther 1989;45:682-691.
4. Buhler FR: Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers. Hypertension 1983;5:III94-III100.
5. Woehler TR, Eff J, Graney W, et al: Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension. Clin Ther 1992;14:148-157.
6. Whelton A, Eff J, Magner DJ: Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring. J Clin Pharmacol 1992;32:808-815.
7. Prisant LM, Bottini B, DiPiro JT, Carr AA: Novel drug-delivery systems for hypertension. Am J Med 1992;93: 45S-55S.
8. Frishman WH: A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension. J Clin Pharmacol 1993;33:612-622.
9. Mimran A, Zambrowski JJ, Coppolani T: The antihypertensive action of indapamide: results of a French multicentre study of 2,184 ambulant patients. Postgrad Med J 1981;2:60-63.
10. Prisant LM, Beall SP, Nichoalds GE, et al: Biochemical, endocrine, and mineral effects of indapamide in black women. J Clin Pharmacol 1990;30:121-126.
11. Abbou CB: The efficacy and tolerance of indapamide in essential hypertension: a multi-centre study in 981 patients. Curr Med Res Opin 1985;9:494-499.
12. Wheeley MS, Bolton JC, Campbell DB: Indapamide in hypertension: a study in general practice of new or previously poorly controlled patients. Pharmatherapeutica 1982;3:143-152.
13. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
14. Prisant LM, Weir MR, Papademetriou V, et al: Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995;130: 359-366.
15. Siegel D, Hulley SB, Black DM, et al: Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 1992;267:1083-1089.
16. Buckley MM, Grant SM, Goa KL, et al: Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39:757-806.
17. Laragh JH: Strategies in choosing therapy for hypertension. In: New Therapeutic Strategies in Hypertension. (Ed. Kaplan NM). Raven Press, New York, 1989, pp141-169.
18. Lacourciere Y, Poirier L, Boucher S, Spenard J: Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins. Clin Pharmacol Ther 1990;48:318-324.
19. Meyer-Sabellek W, Schulte KL, Gotzen R: Non-invasive ambulatory blood pressure monitoring: technical possibilities and problems. J Hypertens Suppl 1990;8:S3-S10.
20. Weber MA, Cheung DG, Graettinger WF, Lipson JL: Characterization of antihypertensive therapy by wholeday blood pressure monitoring. JAMA 1988;259:3281-3285.
21. Prisant LM, Bottini PB, Carr AA: Clinical utility of ambulatory blood pressure monitoring in target organ complications and equipment choices. J Clin Pharmacol 1992;32:620-626.
22. Pickering TG: Can ambulatory blood pressure monitoring improve the diagnosis of mild hypertension? J Hypertens Suppl 1990;8:S43-S47.
23. Prisant LM, Carr AA, Bottini PB, et al: Repeatability of automated ambulatory blood pressure measurements. J Fam Pract 1992;34:569-574.
24. Prisant LM: Ambulatory blood pressure monitoring in the diagnosis of hypertension. Cardiol Clin 1995;13:479-490.
25. O'Brien E, Sheridan J, O'Malley K: Dippers and nondippers. Lancet 1988;2:397.
26. Kannel WB: Hypertension, hypertrophy, and the occurrence of cardiovascular disease. Am J Med Sci 1991;302: 199-204.
27. Ames R, Griffing G, Marbury T, et al: Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertension. Am J Cardiol 1992;69:267-270.
28. Messerli FH, Sundgaard-Riise K, Ventura HO, et al: Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983;2:983-986.
29. Weinberger MH: Additive effects of diuretics or sodium restriction with calcium channel blockers in the treatment of hypertension. J Cardiovasc Pharmacol 1988;12: S72-S75.
30. Burris JF, Weir MR, Oparil S, et al: An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA 1990;263:1507-1512.
31. Fletcher AE, Bulpitt CJ: How far should blood pressure be lowered? N Engl J Med 1992;326:251-254.
32. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
33. Fagan TC: Remembering the lessons of basic pharmacology. Arch Intern Med 1994;154:1430-1431.
34. Fenichel RR, Lipicky RJ: Combination products as first-line pharmacotherapy. Arch Intern Med 1994;154:1429-1430.
35. Kaplan NM: Implications for cost-effectiveness. Combination therapy for systemic hypertension. Am J Cardiol 1995;76:595-597.
36. Chalmers J: The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens 1993;15:1299-1313.
37. Oster JR, Epstein M: Fixed-dose combination medications for the treatment of hypertension: a critical review. J Clin Hypertens 1987;3:278-293.
38. Moser M, Prisant LM: Low-dose combination therapy in hypertension. Am Fam Physician 1997;56:1275-1282.
39. Sutton JM, Bagby SP: Nontraditional combination pharmacotherapy of hypertension. Cleve Clin J Med 1992;59: 459-468.